Free Trial
NASDAQ:INBS

Intelligent Bio Solutions (INBS) Stock Price, News & Analysis

Intelligent Bio Solutions logo
$1.80 -0.03 (-1.64%)
As of 12:55 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Intelligent Bio Solutions Stock (NASDAQ:INBS)

Key Stats

Today's Range
$1.75
$1.85
50-Day Range
$1.15
$1.98
52-Week Range
$1.00
$3.00
Volume
85,952 shs
Average Volume
559,896 shs
Market Capitalization
$12.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Intelligent Bio Solutions Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
8th Percentile Overall Score

INBS MarketRank™: 

Intelligent Bio Solutions scored higher than 8% of companies evaluated by MarketBeat, and ranked 919th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Intelligent Bio Solutions.

  • Earnings Growth

    Earnings for Intelligent Bio Solutions are expected to grow in the coming year, from ($1.25) to $0.35 per share.

  • Price to Book Value per Share Ratio

    Intelligent Bio Solutions has a P/B Ratio of 0.77. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Intelligent Bio Solutions' valuation and earnings.
  • Percentage of Shares Shorted

    8.99% of the float of Intelligent Bio Solutions has been sold short.
  • Short Interest Ratio / Days to Cover

    Intelligent Bio Solutions has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in Intelligent Bio Solutions has recently increased by 15.95%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Intelligent Bio Solutions does not currently pay a dividend.

  • Dividend Growth

    Intelligent Bio Solutions does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.99% of the float of Intelligent Bio Solutions has been sold short.
  • Short Interest Ratio / Days to Cover

    Intelligent Bio Solutions has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in Intelligent Bio Solutions has recently increased by 15.95%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Intelligent Bio Solutions has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Intelligent Bio Solutions this week, compared to 2 articles on an average week.
  • Search Interest

    3 people have searched for INBS on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Intelligent Bio Solutions insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.54% of the stock of Intelligent Bio Solutions is held by insiders.

  • Percentage Held by Institutions

    Only 32.97% of the stock of Intelligent Bio Solutions is held by institutions.

  • Read more about Intelligent Bio Solutions' insider trading history.
Receive INBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter.

INBS Stock News Headlines

Top Picks for Trump’s Pro-Crypto America
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
See More Headlines

INBS Stock Analysis - Frequently Asked Questions

Intelligent Bio Solutions' stock was trading at $1.40 on January 1st, 2025. Since then, INBS stock has increased by 29.6% and is now trading at $1.8150.
View the best growth stocks for 2025 here
.

Intelligent Bio Solutions Inc. (NASDAQ:INBS) posted its earnings results on Thursday, February, 13th. The company reported ($0.50) earnings per share (EPS) for the quarter. The business had revenue of $610 billion for the quarter. Intelligent Bio Solutions had a negative trailing twelve-month return on equity of 176.55% and a negative net margin of 319.85%.

Shares of Intelligent Bio Solutions reverse split on the morning of Monday, January 29th 2024.The 1-12 reverse split was announced on Monday, January 29th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, January 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Intelligent Bio Solutions investors own include SoFi Technologies (SOFI), Plug Power (PLUG), Allarity Therapeutics (ALLR), Adial Pharmaceuticals (ADIL), AMC Entertainment (AMC), ARMOUR Residential REIT (ARR) and BIOLASE (BIOL).

Company Calendar

Last Earnings
2/13/2025
Today
7/03/2025
Next Earnings (Estimated)
9/17/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:INBS
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$10.16 million
Net Margins
-319.85%
Pretax Margin
-320.94%

Debt

Sales & Book Value

Annual Sales
$3.11 million
Price / Cash Flow
N/A
Book Value
$2.37 per share
Price / Book
0.77

Miscellaneous

Free Float
6,804,000
Market Cap
$12.65 million
Optionable
Not Optionable
Beta
4.60
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:INBS) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners